(Foto: Jyrki Siikanen)
Prof. Ann-Christine Syvänen
Ann-Christine.Syvanen@medsci.uu.se
Address:
Molecular Medicine
Department of Medical Sciences
Entrance 70, 3rd floor
Research dept. II
University Hospital
SE-751 85 UPPSALA
 Ann-Christine SyvänenPhD, Professor Research group leader |
 Lillebil AnderssonAdministrative assistant |
 Mathias BrännvallPhD, Project coordinator |
 Eva BerglundPhD, Post doc Epigenetics and genomics of leukemia, bioinformatics. |
 Per WahlbergPhD, Post doc Epigenetics and genomics of leukemia |
 Josefine PallePhD, Post doc Epigenetics and genomics of leukemia |
 Jonas Carlsson Almlöf |
 Per LundmarkPhD, Post doc Genomics, sequencing and SNP bioinformatics |
 Chuan WangPhD student Genetics of autoimmune diseases
|
 Jessica NordlundPhD student Epigenetics and regulation of gene expression in leukemia |
 Mårten LindqvistPhD student Bioinformatics, epigenetics of leukemia |
 Behrooz TorabiMSc, Research assistant Bioinformatics |
 Satyam ManduvaStudent, MSc degree project ENGAGE projekt |
 Anders LundmarkMSc, Research engineer Genetic analyses and bioinformatics |
 Elin ÖvernäsPhD, Research engineer Molecular biological methods |
 Lina SylwanPhD, Research enegineer Molecular biological methods |
 Niklas HenrikssonPhD, Research engineer Molecular biological methods |
 Amanda RainePhD, Research engineer Molecular biological methods |
 Juliana Imgenberg-KreuzMSc, Research assistant Molecular biological methods |
 Olof KarlbergPhD, Senior bioinformatician Genomics, sequencing bioinformatics and systems administration |
 Former member: Johanna SandlingPhD, Post doc Genetics of autoimmune diseases Genetic determinants of growth and birth weight |
2012-04-23
Large grant for epigenetic and genomic analyses of the brain from VR, FAS, Formas and Vinnova to Molecular Medicine and the SNP&SEQ platform.
2012-03-16
The SNP&SEQ Technology Platform has installed a MiSeq instrument from Illumina.
2011-12-14
Molecular Medicine research group has received funding from the Swedish Childhood Cancer Foundation.
2011-11-17
VR-RFI has granted 6.7 million SEK for running costs to the SNP&SEQ platform.
2011-10-04
Molecular Medicine research group has received funding from the K&A Wallenberg foundation.
2011-08-11
A study that doubles the number of susceptibility genes for multiple sclerosis (MS) was published in Nature on Aug 11.
2011-06-20
The SNP&SEQ Technology Platform have now upgraded our Genome Analyzer IIx with a HiSeq 2000 instrument from Illumina.
2011-03-06
Five new loci for coronary artery disease were published on-line in Nature Genetics on March 6th.
2011-01-18
The Molecular Medicine group contributes to the ESGI infra-structure by technology development, eg. allele-specific gene expression and epigenetics.
